Sakarie Mustafe Hidig¹* and Charmarke Mahamoud Ibrahim²

¹Editor-in-Chief, Research Center, Hargeisa Group Hospital, Hargeisa, Somaliland
²Peltier General Hospital, University Hospital Center, Djibouti

*Corresponding Author: Sakarie Mustafe Hidig, Editor-in-Chief, Research Center, Hargeisa Group Hospital, Hargeisa, Somaliland.

Received: June 09, 2025; Published:June 30, 2025

Abstract

Dengue fever, a mosquito-borne viral infection caused by the dengue virus (DENV), remains a significant public health challenge in tropical and subtropical regions. This study aimed to determine the prevalence of dengue fever and analyse the demographic characteristics of patients with positive dengue serology in a specific population. A retrospective analysis was conducted on 100 patients who tested positive for dengue serology between September 2024 and December 2024. Data on age, gender, and test dates were collected and analysed to identify trends in dengue transmission. The results revealed a 100% prevalence rate among the tested population, with 78% of cases occurring in adults (≥18 years) and 22% in children (<18 years). The age range of patients was 13 to 50 years, with a mean age of 35.4 years. Gender distribution was nearly equal, with 52% males and 48% females. Monthly distribution showed a peak in cases during September, October, and November (30 cases each month), followed by a decline in December (10 cases), suggesting a seasonal pattern linked to mosquito activity. The study highlights the significant burden of dengue fever in the studied population, with a broad age range of affected individuals and a balanced gender distribution. The high prevalence among adults, particularly young adults (18–30 years), may reflect greater exposure to mosquito vectors, while the presence of paediatric cases underscores the need for targeted interventions in schools and communities. The seasonal trend observed in this study aligns with the known epidemiology of dengue fever, emphasizing the importance of timing preventive measures to coincide with periods of high transmission. These findings underscore the need for comprehensive public health strategies, including vector control, community education, and early diagnosis, to mitigate the impact of dengue fever. Further research is recommended to explore serotype distribution, risk factors, and clinical outcomes, providing valuable insights for public health planning and intervention strategies.

Keywords: Dengue Fever; World Health Organization

References

1. Hidig SM., et al. “Advancements in Disease Surveillance and Data Coverage in Djibouti: A Commentary and Brief Overview”. International Journal of Advance Research and Innovative Ideas in Education2 (2024).
2. Cen S., et al. “Prevalencia de dengue y leptospirosis en pacientes febriles en un hospital general de especialidades, México [Prevalence of dengue and leptospira in febrile patients of the general hospital of specialities in Mexico]”. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 3 (2018): 332-333.
3. Kamal R., et al. “Culture-positive unilateral panophthalmitis in a serology-positive case of dengue hemorrhagic fever”. Indian Journal of Ophthalmology7 (2018): 1017-1019.
4. Santos TMIL., et al. “Dengue and SARS-CoV-2 co-circulation and overlapping infections in hospitalized patients”. Frontiers in Cellular and Infection Microbiology 14 (2024): 1429309.
5. Oderinde BS., et al. “Prevalence of locally undetected acute infections of Flaviviruses in North-Eastern Nigeria”. Virus Research 286 (2020): 198060.
6. Mota M L., et al. “Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil”. BMC Infectious Diseases1 (2021): 704.
7. Souza Gonçalves M., et al. “Prevalence of arboviruses in sickle cell disease patients from two different regions of Brazil, the North and Northeast”. The Brazilian Journal of Infectious Diseases2 (2024): 103741.
8. Hidig SM. “Advancing Healthcare in East Africa: Challenges, Advancements, and Potential Solutions”. GAS Journal of Clinical Medicine and Medical Research (GASJCMMR) 1 (2024): 6-8.
9. Huang XY., et al. “Outbreak of dengue Fever in central China, 2013”. Biomedical and Environmental Sciences : BES 11 (2024): 894-897.
10. Arai K E., et al. “Performance evaluation of an indirect immunofluorescence kit for the serological diagnosis of dengue”. Einstein (Sao Paulo, Brazil) 18 (2019): eAO5078.
11. Ngwe Tun M M., et al. “Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype”. Infection, Genetics and Evolution 43 (2019): 31-37.
12. Hidig SM. “Dengue Fever Crisis in Somaliland: Overview of Reported Cases and Impacts”. Journal Homepage (2018).
13. Chakravarti A and Kumaria R. “Circulating levels of tumour necrosis factor-alpha and interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak”. The Indian Journal of Medical Research1 (2006): 25-30.
14. Sánchez-Lerma L., et al. “Unexpected arboviruses found in an epidemiological surveillance of acute tropical febrile syndrome in the department of Meta, Eastern Colombia”. Journal of Infection and Public Health9 (2024): 102510.
15. Liew SM., et al. “Dengue in Malaysia: Factors Associated with Dengue Mortality from a National Registry”. PloS One6 (2016): e0157631.
16. Wee L E., et al. “Experience of a Tertiary Hospital in Singapore with Management of a Dual Outbreak of COVID-19 and Dengue”. The American Journal of Tropical Medicine and Hygiene5 (2020): 2005-2011.
17. Dos Santos Carmo AM., et al. “Maintenance of demographic and hematological profiles in a long-lasting dengue fever outbreak: implications for management”. Infectious Diseases of Poverty1 (2016): 84.
18. de Teive E Argolo AF., et al. “High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil”. BMC Infectious Diseases1 (2016): 546.
19. Baba M., et al. “Evidence of arbovirus co-infection in suspected febrile malaria and typhoid patients in Nigeria”. Journal of Infection in Developing Countries1 (2013): 51-59.
20. Aoussi EB., et al. “Seven native cases of dengue in Abidjan, Ivory Coast”. Medecine et Maladies Infectieuses9 (2014): 433-436.
21. Hidig SM., et al. “Advancements in Disease Surveillance and Data Coverage in Djibouti: A Commentary and Brief Overview”. International Journal of Advance Research and Innovative Ideas in Education2 (2024).
22. Humphrey J M., et al. “Dengue in the Middle East and North Africa: A Systematic Review”. PLoS Neglected Tropical Diseases12 (2016): e0005194.
23. Gebremariam TT., et al. “Increasing prevalence of malaria and acute dengue virus coinfection in Africa: a meta-analysis and meta-regression of cross-sectional studies”. Malaria Journal1 (2023): 300.
24. Altassan K K., et al. “Dengue fever in Saudi Arabia: A review of environmental and population factors impacting emergence and spread”. Travel Medicine and Infectious Disease 30 (2019): 46-53.
25. Shimelis T., et al. “Detection of dengue virus infection in children presenting with fever in Hawassa, southern Ethiopia”. Scientific Reports1 (2023): 7997.
26. Alsedig K., et al. “Prevalence of malaria and dengue co-infections among febrile patients during dengue transmission season in Kassala, eastern Sudan”. PLoS Neglected Tropical Diseases10 (2023): e0011660.

Citation

Citation: Sakarie Mustafe Hidig. “Epidemiological Profile of Dengue Fever in Djibouti: A Serological-Based Patient Analysis".Acta Scientific Gastrointestinal Disorders 8.7 (2025): 56-62.

Copyright

Copyright: © 2025 Sakarie Mustafe Hidig. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.